WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that its Chief Operating Officer, Thomas A. Keuer, will present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place September 8-10, 2015 in New York City.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
